首页> 外文OA文献 >P372 Effects of filgotinib on anaemia, thrombocytopenia and leukopenia: Phase 3 study results in patients with active rheumatoid arthritis and prior inadequate response/intolerance to biological DMARDs

【2h】

P372 Effects of filgotinib on anaemia, thrombocytopenia and leukopenia: Phase 3 study results in patients with active rheumatoid arthritis and prior inadequate response/intolerance to biological DMARDs

机译：Filgotinib对贫血，血小板减少症和白细胞减少症的影响：第3阶段研究导致活性类风湿性关节炎的患者和生物DMARD的响应/不容忍患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
R Besuyen; M Genovese; K de Vlam; J E Gottenberg; K Kalunian; B Bartok; Y Tan; Y Guo; C Tasset; J Sundy; D Walker; T Takeuchi;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs [J] . Vibeke Strand, Joel Kremer, Gene Wallenstein, Arthritis Research . 2015,第1期

机译：托法替尼单药治疗对活动性类风湿性关节炎和对DMARDs反应不良的患者的3期随机研究对患者报告结局的影响
2. Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs [J] . Vibeke Str, Joel Kremer, Gene Wallenstein, Arthritis research & therapy. . 2015,第Mara期

机译：TOFACITINIB单药治疗对活性类风湿性关节炎患者的随机阶段3患者患者报告结果的影响，对DMARDS的反应不足
3. Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: A single-center retrospective cohort study (KEIO-TCZ study) at week 52 [J] . Izumi Keisuke, Kaneko Yuko, Yasuoka Hidekata, Modern rheumatology . 2015,第1期

机译：在对DMARDs和/或TNF抑制剂反应不足的活动性类风湿性关节炎患者中，无论有无小剂量甲氨蝶呤，Tocilizumab在临床，功能和影像学上都是安全有效的：每周进行的单中心回顾性队列研究（KEIO-TCZ研究） 52
4. “Don’t Rock the Boat”: A Qualitative Narrative Study Exploring Rheumatoid Arthritis Patients’ Experience of Illness and Biologics [D] . Rachich, Meagan . 2020

机译：“不要摇滚船”：探索类风湿性关节炎患者的疾病和生物学经验的定性叙事研究
5. Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs [O] . Vibeke Strand, Joel Kremer, Gene Wallenstein, 2015

机译：托法替尼单药治疗对活动性类风湿性关节炎和对DMARD反应不足的患者的3期随机研究对患者报告结局的影响
6. FRI0154 SAFETY AND EFFICACY OF FILGOTINIB IN PATIENTS AGED 65 YEARS AND OLDER: RESULTS FROM A PHASE 3 STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS (BDMARD-IR) [O] . Kenneth Kalunian, Jacques-Eric Gottenberg, Mark C. Genovese, 2019

机译：Fri0154菲尔替尼对65岁及以上患者的安全性和有效性：活性类风湿性关节炎患者的第3阶段研究结果和对生物DMARDS的响应或不容忍（BDMARD-IR）的患者

P372 Effects of filgotinib on anaemia, thrombocytopenia and leukopenia: Phase 3 study results in patients with active rheumatoid arthritis and prior inadequate response/intolerance to biological DMARDs

著录项

相似文献

相关主题

期刊订阅